id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02339948
42:71:treatment
Tissue for diagnosis must be obtained by transrectal ultrasound biopsy
2
[ "Tissue", "for", "diagnosis", "must", "be", "obtained", "by", "transrectal", "ultrasound", "biopsy" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT01978509
1:16:chronic_disease
Toxic megacolon
2
[ "Toxic", "megacolon" ]
[ 2, 2 ]
NCT02201992
41:63:treatment
Patients may not be receiving any other investigational agents while on study
2
[ "Patients", "may", "not", "be", "receiving", "any", "other", "investigational", "agents", "while", "on", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT02091999
8:29:chronic_disease
Active Hepatitis C infection
2
[ "Active", "Hepatitis", "C", "infection" ]
[ 0, 2, 2, 2 ]
NCT01639508
1:7:chronic_disease,19:22:chronic_disease,33:41:chronic_disease,49:70:chronic_disease
stroke (including TIA, or other ischemic event) myocardial infarction
2
[ "stroke", "(", "including", "TIA", ",", "or", "other", "ischemic", "event", ")", "myocardial", "infarction" ]
[ 2, 0, 0, 2, 0, 0, 0, 2, 0, 0, 2, 2 ]
NCT02465060
14:40:treatment
Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)
2
[ "Stopping", "the", "anticoagulation", "for", "biopsy", "should", "be", "per", "site", "standard", "operating", "procedure", "(", "SOP", ")" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02947373
20:34:treatment
Patients receiving active therapy on an investigational trial at the time of enrollment should consult with the study chair regarding potential interactions with other study agents
2
[ "Patients", "receiving", "active", "therapy", "on", "an", "investigational", "trial", "at", "the", "time", "of", "enrollment", "should", "consult", "with", "the", "study", "chair", "regarding", "potential", "interactions", "with", "other", "study", "agents" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01684397
33:39:cancer,
Subjects diagnosed with another cancer in the past 3 years
2
[ "Subjects", "diagnosed", "with", "another", "cancer", "in", "the", "past", "3", "years" ]
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT02498535
10:34:treatment,43:56:treatment,106:115:treatment,117:127:treatment,129:139:treatment,143:150:treatment
Use of a nitric oxide donor agent such as nitroglycerin or drugs known to increase methemoglobin such as lidocaine, prilocaine, benzocaine or dapsone at screening
2
[ "Use", "of", "a", "nitric", "oxide", "donor", "agent", "such", "as", "nitroglycerin", "or", "drugs", "known", "to", "increase", "methemoglobin", "such", "as", "lidocaine", ",", "prilocaine", ",", "benzocaine", "or", "dapsone", "at", "screening" ]
[ 0, 0, 0, 1, 1, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0 ]
NCT02359097
42:57:treatment
Subjects who have a contraindication for 3 tesla (T) MRI
2
[ "Subjects", "who", "have", "a", "contraindication", "for", "3", "tesla", "(", "T", ")", "MRI" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0 ]
NCT02570854
11:23:treatment,
Receiving hemodialysis at least 2 times per week
2
[ "Receiving", "hemodialysis", "at", "least", "2", "times", "per", "week" ]
[ 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02950337
1:22:chronic_disease
Chronic heart disease
2
[ "Chronic", "heart", "disease" ]
[ 2, 2, 2 ]
NCT00967785
43:52:chronic_disease
Absence of a documented history of severe infection
2
[ "Absence", "of", "a", "documented", "history", "of", "severe", "infection" ]
[ 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02091999
4:18:treatment,22:43:treatment,,92:110:treatment
no red blood cell or platelet transfusions are allowed within 14 days of the first dose of enfortumab vedotin
2
[ "no", "red", "blood", "cell", "or", "platelet", "transfusions", "are", "allowed", "within", "14", "days", "of", "the", "first", "dose", "of", "enfortumab", "vedotin" ]
[ 0, 1, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02680535
1:19:chronic_disease
metastatic disease
2
[ "metastatic", "disease" ]
[ 2, 2 ]
NCT00739362
1:28:chronic_disease,40:77:chronic_disease,154:186:chronic_disease
Chronic pulmonary disorders, including chronic obstructive pulmonary disease that would limit ability to follow the protocol (investigator judgment) and obstructive sleep apnea syndrome
2
[ "Chronic", "pulmonary", "disorders", ",", "including", "chronic", "obstructive", "pulmonary", "disease", "that", "would", "limit", "ability", "to", "follow", "the", "protocol", "(", "investigator", "judgment", ")", "and", "obstructive", "sleep", "apnea", "syndrome" ]
[ 2, 2, 2, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02563678
23:49:treatment
Medical clearance for hyperbaric oxygen exposure
2
[ "Medical", "clearance", "for", "hyperbaric", "oxygen", "exposure" ]
[ 0, 0, 0, 1, 1, 1 ]
NCT02339233
1:14:chronic_disease,,
severe anemia (Hgb<8 g/dL)
2
[ "severe", "anemia", "(", "Hgb", "<", "8", "g/dL", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02089607
26:66:treatment,115:155:treatment,166:191:treatment,217:232:treatment,254:269:treatment,317:357:treatment,378:395:chronic_disease,397:425:chronic_disease
Participation in another investigational clinical or device trial, with the exception of participation in another investigational endovascular stent-graft protocol, percutaneous aortic valve protocol, or concomitant clinical trials designed to evaluate medical therapy strategies to reduce perioperative risk during fenestrated-branched endovascular repair, including risks of renal dysfunction, contrast-induced nephropathy, neurologic, spinal cord or cardiac complications, and/or use of advanced imaging to reduce radiation exposure during implantation of these devices
2
[ "Participation", "in", "another", "investigational", "clinical", "or", "device", "trial", ",", "with", "the", "exception", "of", "participation", "in", "another", "investigational", "endovascular", "stent-graft", "protocol", ",", "percutaneous", "aortic", "valve", "protocol", ",", "or", "concomitant", "clinical", "trials", "designed", "to", "evaluate", "medical", "therapy", "strategies", "to", "reduce", "perioperative", "risk", "during", "fenestrated-branched", "endovascular", "repair", ",", "including", "risks", "of", "renal", "dysfunction", ",", "contrast-induced", "nephropathy", ",", "neurologic", ",", "spinal", "cord", "or", "cardiac", "complications", ",", "and/or", "use", "of", "advanced", "imaging", "to", "reduce", "radiation", "exposure", "during", "implantation", "of", "these", "devices" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02484404
38:53:cancer,57:82:treatment,87:113:cancer
Patients who have had progression of prostate cancer on prior docetaxel treatment for castrate sensitive disease are ineligible
2
[ "Patients", "who", "have", "had", "progression", "of", "prostate", "cancer", "on", "prior", "docetaxel", "treatment", "for", "castrate", "sensitive", "disease", "are", "ineligible" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 0, 1, 1, 1, 0, 3, 3, 3, 0, 0 ]
NCT01787682
22:40:chronic_disease,51:58:chronic_disease,62:76:chronic_disease
History of untreated metabolic diseases including hepatic or renal disorder
2
[ "History", "of", "untreated", "metabolic", "diseases", "including", "hepatic", "or", "renal", "disorder" ]
[ 0, 0, 0, 2, 2, 0, 2, 0, 2, 2 ]
NCT03158974
1:35:treatment
Oral or parenteral corticosteroids
2
[ "Oral", "or", "parenteral", "corticosteroids" ]
[ 1, 1, 1, 1 ]
NCT01865162
12:33:cancer
History of non-glioma malignancy
2
[ "History", "of", "non-glioma", "malignancy" ]
[ 0, 0, 3, 3 ]
NCT02169739
11:17:chronic_disease,,
Disabling stroke (Rankin Scale ≥4)
2
[ "Disabling", "stroke", "(", "Rankin", "Scale", "≥4", ")" ]
[ 0, 2, 0, 0, 0, 0, 0 ]
NCT02323191
39:59:chronic_disease,161:183:chronic_disease,193:251:chronic_disease,253:274:chronic_disease,,310:321:chronic_disease,326:341:chronic_disease,346:363:chronic_disease,375:404:chronic_disease,432:444:chronic_disease
Evidence of significant, uncontrolled concomitant diseases, which could affect compliance with the protocol or interpretation of results, including significant cardiovascular disease (such as New York Heart Association Class III or IV cardiac disease, myocardial infarction within the last 6 months, unstable arrhythmias, or unstable angina) or pulmonary disease (including obstructive pulmonary disease and history of symptomatic bronchospasm)
2
[ "Evidence", "of", "significant", ",", "uncontrolled", "concomitant", "diseases", ",", "which", "could", "affect", "compliance", "with", "the", "protocol", "or", "interpretation", "of", "results", ",", "including", "significant", "cardiovascular", "disease", "(", "such", "as", "New", "York", "Heart", "Association", "Class", "III", "or", "IV", "cardiac", "disease", ",", "myocardial", "infarction", "within", "the", "last", "6", "months", ",", "unstable", "arrhythmias", ",", "or", "unstable", "angina", ")", "or", "pulmonary", "disease", "(", "including", "obstructive", "pulmonary", "disease", "and", "history", "of", "symptomatic", "bronchospasm", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 2, 0 ]
NCT02414269
15:18:chronic_disease,,
Patients with MPD aged ≥18 years
2
[ "Patients", "with", "MPD", "aged", "≥18", "years" ]
[ 0, 0, 2, 0, 0, 0 ]
NCT02145260
1:11:chronic_disease,
Chronic HD (>90 days)
2
[ "Chronic", "HD", "(", ">", "90", "days", ")" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT02214550
20:52:cancer
presence of active pelvic or abdominal malignancies (primary or metastatic)
2
[ "presence", "of", "active", "pelvic", "or", "abdominal", "malignancies", "(", "primary", "or", "metastatic", ")" ]
[ 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0 ]
NCT02336451
13:38:chronic_disease,42:52:chronic_disease,100:109:treatment,117:136:chronic_disease,182:204:chronic_disease
Patient has impairment of GI function or GI disease that may significantly alter the absorption of ceritinib (e.g., ulcerative diseases, uncontrolled nausea, vomiting, diarrhea, or malabsorption syndrome)
2
[ "Patient", "has", "impairment", "of", "GI", "function", "or", "GI", "disease", "that", "may", "significantly", "alter", "the", "absorption", "of", "ceritinib", "(", "e.g.", ",", "ulcerative", "diseases", ",", "uncontrolled", "nausea", ",", "vomiting", ",", "diarrhea", ",", "or", "malabsorption", "syndrome", ")" ]
[ 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0 ]
NCT02464878
20:35:chronic_disease
Severe co-existing cardiac disease
2
[ "Severe", "co-existing", "cardiac", "disease" ]
[ 0, 0, 2, 2 ]
NCT02145351
35:37:chronic_disease
Hospitalization for decompensated HF
2
[ "Hospitalization", "for", "decompensated", "HF" ]
[ 0, 0, 0, 2 ]
NCT02852239
33:48:chronic_disease
History or current diagnosis of cardiac disease indicating significant risk such as uncontrolled
2
[ "History", "or", "current", "diagnosis", "of", "cardiac", "disease", "indicating", "significant", "risk", "such", "as", "uncontrolled" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02418195
1:4:chronic_disease,26:41:chronic_disease,51:68:chronic_disease
MDD Participants without Suicide Attempt, without SUicidal Ideation
2
[ "MDD", "Participants", "without", "Suicide", "Attempt", ",", "without", "SUicidal", "Ideation" ]
[ 2, 0, 0, 2, 2, 0, 0, 2, 2 ]
NCT00338377
15:24:treatment,97:111:treatment,,165:180:treatment,192:213:treatment,217:242:treatment,,292:307:treatment,,376:379:cancer
Patients with VP shunts must have VP shunts with on/off valves and must be expected to tolerate VP shunt valve off for more than 6 hours Patients who have received CNS irradiation, including whole brain radiation or stereotactic radiosurgery, are eligible, if they are at least 1 weeks post CNS-irradiation (Cohort D)Patients who are currently being treated with IT IL-2 for LMD are eligible. No wash out period is required. (Cohort D)
2
[ "Patients", "with", "VP", "shunts", "must", "have", "VP", "shunts", "with", "on/off", "valves", "and", "must", "be", "expected", "to", "tolerate", "VP", "shunt", "valve", "off", "for", "more", "than", "6", "hours", "Patients", "who", "have", "received", "CNS", "irradiation", ",", "including", "whole", "brain", "radiation", "or", "stereotactic", "radiosurgery", ",", "are", "eligible", ",", "if", "they", "are", "at", "least", "1", "weeks", "post", "CNS-irradiation", "(", "Cohort", "D", ")", "Patients", "who", "are", "currently", "being", "treated", "with", "IT", "IL-2", "for", "LMD", "are", "eligible", ".", "No", "wash", "out", "period", "is", "required", ".", "(", "Cohort", "D", ")" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02466750
32:39:treatment,43:66:treatment,,85:100:treatment
Have administration of another vaccine or investigational product within 28 days of WEE vaccination
2
[ "Have", "administration", "of", "another", "vaccine", "or", "investigational", "product", "within", "28", "days", "of", "WEE", "vaccination" ]
[ 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 1, 1 ]
NCT02698722
1:17:chronic_disease
Stage 4 or 5 CKD
2
[ "Stage", "4", "or", "5", "CKD" ]
[ 2, 2, 2, 2, 2 ]
NCT01894061
15:37:cancer
Patients with leptomeningeal disease
2
[ "Patients", "with", "leptomeningeal", "disease" ]
[ 0, 0, 3, 3 ]
NCT02437851
17:22:cancer,26:39:chronic_disease,43:52:chronic_disease
Concurrent anal canal or perianal HSIL or condyloma that in the judgment of the clinician cannot be cleared or can only be cleared with undue morbidity to the patient
2
[ "Concurrent", "anal", "canal", "or", "perianal", "HSIL", "or", "condyloma", "that", "in", "the", "judgment", "of", "the", "clinician", "can", "not", "be", "cleared", "or", "can", "only", "be", "cleared", "with", "undue", "morbidity", "to", "the", "patient" ]
[ 0, 0, 3, 0, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02412540
1:28:chronic_disease,64:67:treatment,91:94:chronic_disease,106:139:chronic_disease,
Active psychiatric disorder that would prevent eligibility for WLS or impede adherence to CLI, including clinically significant depression (hospitalization or suicidal ideation) in past 12 months
2
[ "Active", "psychiatric", "disorder", "that", "would", "prevent", "eligibility", "for", "WLS", "or", "impede", "adherence", "to", "CLI", ",", "including", "clinically", "significant", "depression", "(", "hospitalization", "or", "suicidal", "ideation", ")", "in", "past", "12", "months" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02833207
26:39:chronic_disease
Self-reported history of renal disease
2
[ "Self-reported", "history", "of", "renal", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT02755896
29:60:cancer,68:88:treatment,114:151:cancer
Presence of a proportion of Ductal Carcinoma in-situ (DCIS) in the core biopsy specimen which is compatible with extensive intraductal component (EIC)
2
[ "Presence", "of", "a", "proportion", "of", "Ductal", "Carcinoma", "in-situ", "(", "DCIS", ")", "in", "the", "core", "biopsy", "specimen", "which", "is", "compatible", "with", "extensive", "intraductal", "component", "(", "EIC", ")" ]
[ 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0 ]
NCT03060772
12:26:cancer
History of bladder cancer
2
[ "History", "of", "bladder", "cancer" ]
[ 0, 0, 3, 3 ]
NCT02905370
1:22:treatment
Post-op bowel surgery
2
[ "Post-op", "bowel", "surgery" ]
[ 1, 1, 1 ]
NCT00967577
28:47:allergy_name
Prior allergic reaction to Gadolinium contrast
2
[ "Prior", "allergic", "reaction", "to", "Gadolinium", "contrast" ]
[ 0, 0, 0, 0, 4, 4 ]
NCT02131389
19:41:chronic_disease,48:68:chronic_disease,70:99:chronic_disease,101:120:chronic_disease,122:150:chronic_disease
Is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.)
2
[ "Is", "suffering", "from", "inflammatory", "arthritis", "(", "e.g", ".", "rheumatoid", "arthritis", ",", "juvenile", "rheumatoid", "arthritis", ",", "psoriatic", "arthritis", ",", "systemic", "lupus", "erythematosus", ",", "etc", ".", ")" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0 ]
NCT03014687
1:17:chronic_disease
Active sinusitis
2
[ "Active", "sinusitis" ]
[ 2, 2 ]
NCT02916472
26:32:cancer
histologically confirmed cancer
2
[ "histologically", "confirmed", "cancer" ]
[ 0, 0, 3 ]
NCT02099058
17:49:treatment,78:87:treatment,92:101:treatment
Subjects in the combination therapy arms A and D must be eligible to receive erlotinib, or nivolumab per most current prescribing information, or at the discretion of the Investigator
2
[ "Subjects", "in", "the", "combination", "therapy", "arms", "A", "and", "D", "must", "be", "eligible", "to", "receive", "erlotinib", ",", "or", "nivolumab", "per", "most", "current", "prescribing", "information", ",", "or", "at", "the", "discretion", "of", "the", "Investigator" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02319369
14:23:treatment,42:52:cancer,,109:120:treatment,,191:200:treatment
received any therapies intended to treat malignancy within 14 days of first receipt of DS-3032b [except for hydroxyurea, which must be discontinued at least 48 hours (Day -2) prior to study treatment]
2
[ "received", "any", "therapies", "intended", "to", "treat", "malignancy", "within", "14", "days", "of", "first", "receipt", "of", "DS-3032b", "[", "except", "for", "hydroxyurea", ",", "which", "must", "be", "discontinued", "at", "least", "48", "hours", "(", "Day", "-2", ")", "prior", "to", "study", "treatment", "]" ]
[ 0, 0, 1, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT03042689
,,,104:110:cancer
Alkaline phosphatase limit ≤ 2.5 x ULN (≤ 5 x ULN for subjects with liver or bone involvement of their cancer)
2
[ "Alkaline", "phosphatase", "limit", "≤", "2.5", "x", "ULN", "(", "≤", "5", "x", "ULN", "for", "subjects", "with", "liver", "or", "bone", "involvement", "of", "their", "cancer", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0 ]
NCT02907983
1:11:treatment,13:22:treatment,64:84:treatment
pregabalin, clonidine, selective estrogen receptor modulators, aromatase inhibitors, tissue selective estrogen complexes
2
[ "pregabalin", ",", "clonidine", ",", "selective", "estrogen", "receptor", "modulators", ",", "aromatase", "inhibitors", ",", "tissue", "selective", "estrogen", "complexes" ]
[ 1, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02004275
27:46:chronic_disease
No clinically significant pericardial disease
2
[ "No", "clinically", "significant", "pericardial", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT02089607
31:54:treatment
In such a situation, multiple extra-anatomic bypasses may be necessary
2
[ "In", "such", "a", "situation", ",", "multiple", "extra-anatomic", "bypasses", "may", "be", "necessary" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT02494869
1:18:chronic_disease
Recurrent syncope
2
[ "Recurrent", "syncope" ]
[ 2, 2 ]
NCT02253316
1:22:chronic_disease
secondary amyloidosis
2
[ "secondary", "amyloidosis" ]
[ 2, 2 ]
NCT02442102
8:24:chronic_disease
Active seizure disorder
2
[ "Active", "seizure", "disorder" ]
[ 0, 2, 2 ]
NCT02138214
1:29:chronic_disease,76:94:chronic_disease,98:115:chronic_disease
Chronic neurologic condition which affects voice or swallow (for instance, multiple sclerosis or Parkinson disease)
2
[ "Chronic", "neurologic", "condition", "which", "affects", "voice", "or", "swallow", "(", "for", "instance", ",", "multiple", "sclerosis", "or", "Parkinson", "disease", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0 ]
NCT03160547
1:11:chronic_disease
Sarcopenia
2
[ "Sarcopenia" ]
[ 2 ]
NCT02233868
1:19:treatment
antianginal agents
2
[ "antianginal", "agents" ]
[ 1, 1 ]
NCT00432094
51:66:chronic_disease
Patients must be free of symptoms of uncontrolled cardiac disease
2
[ "Patients", "must", "be", "free", "of", "symptoms", "of", "uncontrolled", "cardiac", "disease" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02234934
14:30:chronic_disease
Uncontrolled seizure disorder
2
[ "Uncontrolled", "seizure", "disorder" ]
[ 0, 2, 2 ]
NCT02329652
39:60:chronic_disease
subjects should not have a history of autonomic dysreflexia
2
[ "subjects", "should", "not", "have", "a", "history", "of", "autonomic", "dysreflexia" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02019641
13:41:chronic_disease
Significant hepatic or renal dysfunction
2
[ "Significant", "hepatic", "or", "renal", "dysfunction" ]
[ 0, 2, 2, 2, 2 ]
NCT02459769
25:31:cancer
Have had a diagnosis of cancer
2
[ "Have", "had", "a", "diagnosis", "of", "cancer" ]
[ 0, 0, 0, 0, 0, 3 ]
NCT02547818
22:28:chronic_disease
Uncontrolled chronic asthma
2
[ "Uncontrolled", "chronic", "asthma" ]
[ 0, 0, 2 ]
NCT02424968
30:41:chronic_disease,43:54:chronic_disease,72:83:chronic_disease,94:127:chronic_disease,138:182:chronic_disease
Must not be seropositive for HIV 1 and 2, hepatitis B surface antigen, hepatitis C antibody, human T-lymphotropic virus (HTLV) antibody, cytomegalovirus (CMV) immunoglobulin M (IgM), or rapid plasma reagin (RPR) (Treponema)
2
[ "Must", "not", "be", "seropositive", "for", "HIV", "1", "and", "2", ",", "hepatitis", "B", "surface", "antigen", ",", "hepatitis", "C", "antibody", ",", "human", "T-lymphotropic", "virus", "(", "HTLV", ")", "antibody", ",", "cytomegalovirus", "(", "CMV", ")", "immunoglobulin", "M", "(", "IgM", ")", ",", "or", "rapid", "plasma", "reagin", "(", "RPR", ")", "(", "Treponema", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02308202
87:91:chronic_disease
We anticipate that participants will be on a wide range of medications prescribed for PTSD
2
[ "We", "anticipate", "that", "participants", "will", "be", "on", "a", "wide", "range", "of", "medications", "prescribed", "for", "PTSD" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02389465
22:28:cancer
Current diagnosis of cancer
2
[ "Current", "diagnosis", "of", "cancer" ]
[ 0, 0, 0, 3 ]
NCT00862433
12:22:treatment,34:41:treatment,54:78:treatment,80:103:treatment,108:119:treatment
No regular medication other than aspirin (other than oral hypoglycemic agents, hormonal contraceptives and medications taken only on an as-needed basis)
2
[ "No", "regular", "medication", "other", "than", "aspirin", "(", "other", "than", "oral", "hypoglycemic", "agents", ",", "hormonal", "contraceptives", "and", "medications", "taken", "only", "on", "an", "as-needed", "basis", ")" ]
[ 0, 0, 1, 0, 0, 1, 0, 0, 0, 1, 1, 1, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02828618
1:9:chronic_disease
Dementia or significantly altered mental status that would prohibit the understanding and giving of informed consent
2
[ "Dementia", "or", "significantly", "altered", "mental", "status", "that", "would", "prohibit", "the", "understanding", "and", "giving", "of", "informed", "consent" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02195232
20:64:chronic_disease
Known diagnosis of disseminated intravascular coagulation (DIC)
2
[ "Known", "diagnosis", "of", "disseminated", "intravascular", "coagulation", "(", "DIC", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02148796
21:27:chronic_disease
Parental history of asthma
2
[ "Parental", "history", "of", "asthma" ]
[ 0, 0, 0, 2 ]
NCT02990481
1:29:cancer
Symptomatic brain metastases
2
[ "Symptomatic", "brain", "metastases" ]
[ 3, 3, 3 ]
NCT03060473
4:12:treatment
on dialysis
2
[ "on", "dialysis" ]
[ 0, 1 ]
NCT02312570
1:24:chronic_disease,25:30:chronic_disease,25:31:chronic_disease,164:172:chronic_disease,174:184:chronic_disease,186:195:treatment,197:207:chronic_disease,209:234:chronic_disease,236:242:chronic_disease,247:264:chronic_disease
Stage I pressure ulcers Ulcers that are unstageable or of deep tissue morphology that have yet to become an open wound Ulcer not of PU pathophysiology (e.g., pure diabetic, vasculitic, radiation, rheumatoid, collagen vascular disease, venous, or arterial etiology)
2
[ "Stage", "I", "pressure", "ulcers", "Ulcers", "that", "are", "unstageable", "or", "of", "deep", "tissue", "morphology", "that", "have", "yet", "to", "become", "an", "open", "wound", "Ulcer", "not", "of", "PU", "pathophysiology", "(", "e.g.", ",", "pure", "diabetic", ",", "vasculitic", ",", "radiation", ",", "rheumatoid", ",", "collagen", "vascular", "disease", ",", "venous", ",", "or", "arterial", "etiology", ")" ]
[ 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 1, 0, 2, 0, 2, 2, 2, 0, 2, 0, 0, 2, 2, 0 ]
NCT02343042
1:27:chronic_disease,
Myocardial infarction (MI) within 3 months prior to C1D1
2
[ "Myocardial", "infarction", "(", "MI", ")", "within", "3", "months", "prior", "to", "C1D1" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02958462
1:25:chronic_disease,31:49:cancer,66:86:cancer,88:118:chronic_disease
Marrow failure syndromes with myeloid malignancy predisposition- telomere dysfunction, chromosomal breakage disorders, etc
2
[ "Marrow", "failure", "syndromes", "with", "myeloid", "malignancy", "predisposition-", "telomere", "dysfunction", ",", "chromosomal", "breakage", "disorders", ",", "etc" ]
[ 2, 2, 2, 0, 3, 3, 0, 3, 3, 0, 2, 2, 2, 0, 0 ]
NCT00737893
1:48:chronic_disease
Nonarteritic Anterior Ischemic Optic Neuropathy
2
[ "Nonarteritic", "Anterior", "Ischemic", "Optic", "Neuropathy" ]
[ 2, 2, 2, 2, 2 ]
NCT03040778
21:57:chronic_disease
Patients with known hemorrhagic and coagulation disorder
2
[ "Patients", "with", "known", "hemorrhagic", "and", "coagulation", "disorder" ]
[ 0, 0, 0, 2, 2, 2, 2 ]
NCT01624090
38:55:treatment,48:55:treatment,96:108:treatment,
Patients may have received localized radiation therapy to non-target lesions provided that the radiotherapy is completed 14 days prior to commencing therapy, and the patient has recovered from any toxicity
2
[ "Patients", "may", "have", "received", "localized", "radiation", "therapy", "to", "non-target", "lesions", "provided", "that", "the", "radiotherapy", "is", "completed", "14", "days", "prior", "to", "commencing", "therapy", ",", "and", "the", "patient", "has", "recovered", "from", "any", "toxicity" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02914834
1:29:treatment
concomitant physical therapy
2
[ "concomitant", "physical", "therapy" ]
[ 1, 1, 1 ]
NCT02890979
32:53:cancer,64:71:chronic_disease,88:126:chronic_disease
Subjects with risk factors for esophageal malignancy including Barrett?s esophagus and gastroesophageal reflux disease (GERD)
2
[ "Subjects", "with", "risk", "factors", "for", "esophageal", "malignancy", "including", "Barrett", "?", "s", "esophagus", "and", "gastroesophageal", "reflux", "disease", "(", "GERD", ")" ]
[ 0, 0, 0, 0, 0, 3, 3, 0, 2, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02495389
13:32:treatment
Patients on current OAB therapy will undergo a two-week drug washout period prior to baseline assessment
2
[ "Patients", "on", "current", "OAB", "therapy", "will", "undergo", "a", "two-week", "drug", "washout", "period", "prior", "to", "baseline", "assessment" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02585973
1:7:treatment,15:38:cancer,40:46:cancer,48:59:cancer,64:75:cancer,,
Biopsy proven HNSCC of the oropharynx, larynx, hypopharynx, or oral cavity Stage III-IVB as defined by American Joint Committee on Cancer (AJCC) T0-T4, N0 - N3, M0
2
[ "Biopsy", "proven", "HNSCC", "of", "the", "oropharynx", ",", "larynx", ",", "hypopharynx", ",", "or", "oral", "cavity", "Stage", "III-IVB", "as", "defined", "by", "American", "Joint", "Committee", "on", "Cancer", "(", "AJCC", ")", "T0-T4", ",", "N0", "-", "N3", ",", "M0" ]
[ 1, 0, 3, 3, 3, 3, 0, 3, 0, 3, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02346526
1:10:treatment
Treatment should be completed for spinal cord compression
2
[ "Treatment", "should", "be", "completed", "for", "spinal", "cord", "compression" ]
[ 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02133885
24:32:treatment,,,
one of which must be a diuretic (with no changes for a minimum of two weeks prior to screening) that is expected to be maintained without changes for at least 6-9 months
2
[ "one", "of", "which", "must", "be", "a", "diuretic", "(", "with", "no", "changes", "for", "a", "minimum", "of", "two", "weeks", "prior", "to", "screening", ")", "that", "is", "expected", "to", "be", "maintained", "without", "changes", "for", "at", "least", "6-9", "months" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02359253
24:30:cancer,32:40:cancer,44:55:cancer
First focal unilateral lesion, ischemic or hemorrhagic
2
[ "First", "focal", "unilateral", "lesion", ",", "ischemic", "or", "hemorrhagic" ]
[ 0, 0, 0, 3, 0, 3, 0, 3 ]
NCT02574910
1:10:treatment
Treatment with growth hormone at enrollment or during the course of the study
2
[ "Treatment", "with", "growth", "hormone", "at", "enrollment", "or", "during", "the", "course", "of", "the", "study" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02115295
55:81:cancer,83:111:cancer,115:118:cancer
For Salvage cohort: Patients with previously treated, relapsed or refractory AML, Acute Biphenotypic Leukemia, or CML in Myeloid Blast Phase are eligible
2
[ "For", "Salvage", "cohort", ":", "Patients", "with", "previously", "treated", ",", "relapsed", "or", "refractory", "AML", ",", "Acute", "Biphenotypic", "Leukemia", ",", "or", "CML", "in", "Myeloid", "Blast", "Phase", "are", "eligible" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 3, 3, 3, 0, 0, 3, 0, 0, 0, 0, 0, 0 ]
NCT02663596
76:86:allergy_name
History of any moderate or severe hypersensitivity or allergic reaction to vancomcyin (a history of mild rash followed by uneventful re-exposure and/or red man syndrome is not a contraindication)
2
[ "History", "of", "any", "moderate", "or", "severe", "hypersensitivity", "or", "allergic", "reaction", "to", "vancomcyin", "(", "a", "history", "of", "mild", "rash", "followed", "by", "uneventful", "re-exposure", "and/or", "red", "man", "syndrome", "is", "not", "a", "contraindication", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03066596
28:34:chronic_disease
Persistent or uncontrolled asthma as per clinic assessment
2
[ "Persistent", "or", "uncontrolled", "asthma", "as", "per", "clinic", "assessment" ]
[ 0, 0, 0, 2, 0, 0, 0, 0 ]
NCT02503709
16:37:treatment,,,,,,,,,,,,786:836:treatment,895:929:treatment
The effects of onalespib and AT7519M on the developing human fetus are unknown; for this reason, women of childbearing potential and male patients with partners of childbearing potential must agree to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry, for the duration of study participation, and for 2 months after completion of study; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately; women of childbearing potential enrolling on study must have a negative pregnancy test within 72 hours of enrollment in order to be eligible; because there is an unknown but potential risk to nursing infants secondary to treatment of the mother with onalespib and AT7519M, breastfeeding should be discontinued while the mother is treated with onalespib and AT7519M
2
[ "The", "effects", "of", "onalespib", "and", "AT7519M", "on", "the", "developing", "human", "fetus", "are", "unknown", ";", "for", "this", "reason", ",", "women", "of", "childbearing", "potential", "and", "male", "patients", "with", "partners", "of", "childbearing", "potential", "must", "agree", "to", "use", "adequate", "contraception", "(", "hormonal", "or", "barrier", "method", "of", "birth", "control", "or", "abstinence", ")", "prior", "to", "study", "entry", ",", "for", "the", "duration", "of", "study", "participation", ",", "and", "for", "2", "months", "after", "completion", "of", "study", ";", "should", "a", "woman", "become", "pregnant", "or", "suspect", "she", "is", "pregnant", "while", "she", "or", "her", "partner", "is", "participating", "in", "this", "study", ",", "she", "should", "inform", "her", "treating", "physician", "immediately", ";", "women", "of", "childbearing", "potential", "enrolling", "on", "study", "must", "have", "a", "negative", "pregnancy", "test", "within", "72", "hours", "of", "enrollment", "in", "order", "to", "be", "eligible", ";", "because", "there", "is", "an", "unknown", "but", "potential", "risk", "to", "nursing", "infants", "secondary", "to", "treatment", "of", "the", "mother", "with", "onalespib", "and", "AT7519M", ",", "breastfeeding", "should", "be", "discontinued", "while", "the", "mother", "is", "treated", "with", "onalespib", "and", "AT7519M" ]
[ 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1 ]
NCT02924194
28:44:chronic_disease
Subjects with a history of seizure disorder
2
[ "Subjects", "with", "a", "history", "of", "seizure", "disorder" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT01684904
1:22:treatment
Endoscopic ultrasound
2
[ "Endoscopic", "ultrasound" ]
[ 1, 1 ]
NCT01481974
1:12:chronic_disease
Hepatitis C positive donor liver
2
[ "Hepatitis", "C", "positive", "donor", "liver" ]
[ 2, 2, 0, 0, 0 ]
NCT03058952
1:32:chronic_disease
antisocial personality disorder
2
[ "antisocial", "personality", "disorder" ]
[ 2, 2, 2 ]
NCT02543866
,24:33:chronic_disease
A history at least one infection due to ESC-R Enterobacteriaceae
2
[ "A", "history", "at", "least", "one", "infection", "due", "to", "ESC-R", "Enterobacteriaceae" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0 ]
NCT02865135
1:10:chronic_disease
mucositis
2
[ "mucositis" ]
[ 2 ]
NCT02132130
1:17:treatment
Previous surgery in the study ear
2
[ "Previous", "surgery", "in", "the", "study", "ear" ]
[ 1, 1, 0, 0, 0, 0 ]
NCT03149783
1:14:chronic_disease
schizophrenia
2
[ "schizophrenia" ]
[ 2 ]